"Degalix 120mg Injection is a pharmaceutical preparation containing DEGARELIX as its active ingredient, classified under the Hormonal Therapy general category and the Hormonal Therapy speciality domain. Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist that immediately blocks GnRH receptors in the pituitary gland, rapidly reducing testosterone production without the initial testosterone surge seen with GnRH agonists. Manufactured by BDR PHARMACEUTICALS INTERNATIONALS PVT LTD. As with any prescription medicine, dosage and treatment duration must be individualised by the treating specialist based on the patient's diagnosis, disease stage, organ function, and concurrent medications.

Uses of Degalix 120mg Injection
Used in the treatment of advanced hormone-dependent prostate cancer.

Degalix 120mg Injection containing DEGARELIX works as described: Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist that immediately blocks GnRH receptors in the pituitary gland, rapidly reducing testosterone production without the initial testosterone surge seen with GnRH agonists. Therapeutically, it is classified under the Hormonal Therapy category and Hormonal Therapy speciality domain. Regular monitoring by the treating specialist is recommended to assess treatment response and manage side effects.

• Always inform your doctor about every medicine, supplement, or herbal product you are currently taking before starting Degalix 120mg Injection. Caution with drugs that prolong the QT interval; inform your doctor of any heart conditions before starting treatment.

Degalix 120mg Injection is available under medical guidance and should be used strictly as advised by a licensed specialist. Storage: Store below 25°C. Protect from light. Disposal: Do not flush unused product or dispose of it in household waste; return unused or expired product to a licensed pharmacy. Manufactured by BDR PHARMACEUTICALS INTERNATIONALS PVT LTD and complies with applicable regulatory standards.